Articles tagged with Opioids
A recent study published by the University of the Basque Country found that girls are the biggest consumers of psychotropic drugs among adolescents in most European countries. The research team analyzed data from 32 European countries and discovered a significant link between consumption rates, gender equality, and economic level.
Lurie Children's Hospital of Chicago has successfully eliminated months of postoperative pain for microtia patients through a minimally invasive nerve freezing procedure. The method, which lasts only 20 minutes, allows patients to enjoy natural ear sensation and appearance without prolonged pain or opioid use.
A cohort study found that Medicaid prescription caps were associated with lower overall prescription medication use and greater frequency of acute care visits among young adults with opioid use disorder. This suggests that the implementation of these caps may have unintended consequences for individuals struggling with addiction.
A large cohort study found that antenatal opioid exposure was associated with impaired cerebral cortical folding in newborns. The extent of impairment differed based on the opioid type and presence of polysubstance exposure. Longitudinal assessments aim to inform early interventions for vulnerable populations.
A recent study found significant increases in amputation rates among both opioid- and non-opioid-related hospitalizations between 2016 and 2022. Opioid-related amputations were more common at higher anatomical levels, highlighting the need for earlier intervention to prevent severe harm.
A multi-institutional team led by Sanford Burnham Prebys aims to develop a non-opioid pain therapeutic using lead molecule SBI-810. The effort, funded by a $3.9 million NIH grant, seeks to optimize the compound into a drug that could provide effective pain relief without addiction risks.
Historian Benjamin R. Siegel's book 'Markets of Pain' explores how opium was used as a commodity to wield power and control supply chains, contributing to the opioid epidemic. India's unique history with opium production, inherited from colonial era systems, is also examined.
A randomized clinical trial found symptom-based dosing decreases discharge time compared to scheduled opioid taper approaches among infants with opioid withdrawal. This approach, using Eat, Sleep, Console, led to faster recovery and improved outcomes.
A new study shows that while dental opioid prescription fills in the US have dropped by 27% since 2021, the rate remains higher than in other developed countries and the US territory of Puerto Rico. The study suggests that some US dentists are still overprescribing opioids.
A cross-sectional study found a substantial increase in medication use for opioid use disorder among Medicaid beneficiaries, potentially contributing to reductions in overdose deaths. The study suggests that expanding access to medications for opioid use disorder may be an effective strategy to address the opioid crisis.
A retrospective cohort study found that outpatient early methadone dose titration is associated with improved treatment retention in individuals using fentanyl. This approach also lowers the risk of opioid toxicity, according to Canadian and US clinical guidance.
A recent study found a decline in long-term opioid prescribing in the US between 2015 and 2023, with a 24.3% decrease in patients receiving extended therapy. However, approximately 4.2 million US patients still received opioids for 90 days or longer in 2023, indicating the need for improved treatment models for chronic pain management.
Long-term opioid therapy prescription rates declined in the US from 2015 to 2023, despite a growing population of older adults receiving these treatments. Approximately 4-5 million patients were prescribed long-term opioids in 2023, with Medicare covering a larger proportion, raising concerns about safety.
Researchers at NIH have identified a novel opioid compound that shows potential as a therapy for both pain and opioid use disorder. The new drug, called DFNZ, has high pain-relieving effects without causing respiratory depression or addiction.
A new study proposes that the brain's reward system is built to optimize energy, not pleasure. Researchers argue that dopamine and opioids function as physiological agents to manage the body's energetic budget, guiding behavior and learning.
The UT Health San Antonio School of Dentistry has secured a $9 million NIH grant to develop a targeted, non-opioid treatment for chronic pain associated with muscle and joint dysfunction. Researchers will map the biology of facial pain, identify specialized neurons, and analyze gene expression changes to design effective treatments.
The study found that opioids provide only small, time-limited pain relief for certain pain conditions, such as stomach pain and dental surgery. Regular use of opioids comes with a risk of harm, including dependence and overdose.
A new study published in JAMA found that emergency department-initiated buprenorphine for opioid use disorder was well-tolerated and effective, with a low risk of withdrawal. The 7-day extended-release and sublingual buprenorphine groups showed similar treatment engagement rates on day 7.
A new study found that removing legal barriers to cannabis use may reduce daily opioid use and lower the risk of opioid-related overdoses among people who inject drugs. US states that legalized recreational cannabis saw a 9-to-11-percentage-point decline in daily opioid use among this population.
A new systematic review and meta-analysis by Penn Nursing researchers has identified four primary patient-related risk factors that predict chronic opioid use after surgery. These include Medicaid enrollment, preoperative benzodiazepine use, mood disorders, and anxiety. The study's findings provide a roadmap for clinicians to implement...
Research shows that methadone and buprenorphine prescriptions have risen significantly since 2010, reducing opioid-related deaths by half. However, only a quarter of individuals with opioid use disorder receive medication treatment, highlighting the need for expanded access to these life-saving medications.
Research suggests that blocking growth factor receptor signaling using cancer drugs may overcome two challenges: managing oral cancer pain and preventing opioid tolerance. This approach could control cancer while addressing pain through a non-opioid, biologically rational approach.
A 2025 survey found that U.S. adults view opioid overdose as a serious problem, with differing opinions on who is responsible for reducing overdose rates. The study suggests varying preferences for future actions to address overdose among conservatives, moderates, and liberals.
Financial settlements from opioid epidemic lawsuits are being redirected to fund potentially lifesaving interventions. These efforts aim to curb overdose deaths and improve public health outcomes.
A new study by the University of Texas at Arlington examines how updated CDC guidelines can help nurse practitioners reduce opioid misuse and protect patients. The guidelines emphasize individualized care, clinical judgment, and ongoing reassessment to ensure safe prescribing practices.
Researchers seek to improve burn trauma care by targeting a signaling kinase enzyme with a new-generation inhibitor. The goal is to reduce opioids needed for pain relief and scarring, improving patient recovery from trauma injury.
Researchers identified bradycardia as a symptom of xylazine-opioid overdose, particularly in the Northeast, where xylazine is more prevalent. This finding may aid emergency medicine physicians in detecting xylazine exposure and providing harm reduction counseling.
A new study of over 32,000 US Veterans found that longer treatment with medications for opioid use disorder is associated with a greater probability of short- and medium-term survival. The benefit continues to increase at least for four years of ongoing treatment.
This randomized clinical trial found yoga to significantly accelerate opioid withdrawal recovery and improve autonomic regulation, anxiety, sleep, and pain. The study supports the integration of yoga into withdrawal protocols as a neurobiologically informed intervention addressing core regulatory processes.
Researchers distinguish between medical and community-based approaches to safe supply, proposing a framework for better describing care models. The study aims to inform policy changes and improve access to care, decrease overdoses, and reduce stigma around people who use drugs.
Researchers found that abstinent smokers have altered brain activity linked to increased pain sensitivity and a need for more postoperative pain relief. The study suggests that nicotine withdrawal affects specific brain regions, leading to higher requirements for pain management in surgery.
A cohort study found that participation in New York's medical cannabis program was associated with lower rates of opioid prescription during a 18-month follow-up. The study controlled for unregulated cannabis use, suggesting that medical cannabis may be an effective alternative to opioids for managing chronic pain.
The company has secured $5 million in funding to support Phase 1 and pivotal trials for its therapies aimed at addressing opioid-induced respiratory depression and improving anesthesia recovery. This financing marks a transformative moment for OYE Therapeutics, positioning the company to enter clinical development with confidence.
Researchers have identified a previously unknown sodium-binding site on GlyT2, which supplies the energetic drive required for glycine transport. The study also uncovered a distinctive allosteric binding pocket for lipid-based inhibitors, providing a foundation for rational design of improved analgesics.
The prevalence of injecting methamphetamine only or both methamphetamine and opioids increased among people who inject drugs entering treatment in the US between 2012 and 2023. This trend is consistent with prior work showing increases in opioid and methamphetamine co-use before the COVID-19 pandemic.
This study confirms the role of negative reinforcement in chronic opioid use, contributing to addiction development. The findings suggest that this mechanism is present even after regular opioid use, highlighting potential for more effective prevention and treatment strategies.
A new study reveals that laws restricting pain clinics, or 'pill mills,' where opioids were often prescribed, reduced risky opioid use by 5 percent. Enacting such laws near the onset of the crisis in the 1990s could have reduced risky use by 30 percent over time.
A Norwegian study of over 21,000 adolescents and young adults found that those with persistent parental opioid prescriptions faced more than double the risk of persistent opioid use. The study suggests considering family-based approaches to managing pain conditions in adolescents and young adults.
A new study finds that ChatGPT can provide trustworthy information for pregnant women seeking medical advice on treating opioid use disorder, with over 97% of responses scoring as safe and accurate. The researchers used a persona to frame conversations with the AI, which showed consistency with accepted clinical practice.
A recent study found that cannabis may reduce opioid use among commercially insured patients with cancer diagnoses, indicating potential benefits for pain management. However, further research is needed to confirm the efficacy of cannabis as a treatment for cancer-related pain.
A study published in The Lancet Primary Care found that older adults with HIV are more likely to receive opioids and experience opioid use disorder compared to those without HIV. This disparity highlights the need for tailored strategies to safely prescribe opioids and expand access to treatment.
A recent study found that primary care providers in Ohio perceive and treat opioid use disorder (OUD) differently from other chronic conditions like type 2 diabetes. Despite recognizing OUD as a chronic brain disease, providers were less likely to offer treatment themselves.
Research reveals an increase in emergency calls for pediatric opioid exposure among middle-school aged children, with a national trend of rising calls from 255 in 2019 to 553 in 2023. Teenagers showed a decline after 2022. Demographics varied by age group, with females outnumbering males in the middle school age group.
A recent analysis reveals a modest decline in new and additional opioid prescriptions for patients with cancer from 2016 to 2020. For patients with metastatic cancer, prescribing remained stable for those reporting any pain but declined steeply for those reporting no pain.
A new study finds that prompt administration of opioid pain relief in emergency departments can reduce hospitalization rates for children with sickle cell disease. Children who received timely first-dose administration within 60 minutes and second-dose administration within 30 minutes showed reduced hospitalization odds.
A Swedish study of over 1.2 million children found no significant association between prenatal exposure to opioids and increased risk of autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD). The researchers attributed the observed differences in ASD rates among exposed versus unexposed children to other pre...
A new study published in the American Cancer Society's journal reveals that nearly 1 in 10 patients undergoing surgery for early-stage cancer will initiate opioid prescriptions long-term. The research found that those with a prior history of chronic pain, comorbidities, and lower socioeconomic status were at higher risk.
A new study from the University of Colorado Anschutz Medical Campus introduces a more individualized approach to restarting methadone treatment for people with opioid use disorder. The findings suggest that tailoring methadone doses to each patient's unique circumstances can improve care without compromising safety.
Researchers at Kyoto University have discovered a novel analgesic called ADRIANA, which targets the α2B-adrenoceptor and exerts its effect without causing cardiovascular instability. The compound has shown highly promising results in non-clinical studies and early clinical trials.
Researchers detected traces of nitazene in discarded injecting equipment and syringes in Adelaide, Australia. Nitazenes led to 32 overdose deaths with 84% of patients unaware of the synthetic opioid's presence.
A study of 22 million urgent care visits found 12.4% of patients received antibiotics, 9.1% glucocorticoids, and 1.3% opioids for generally inappropriate diagnoses. The trends highlight the need for improved clinician knowledge, patient demand, and decision support.
A study published in Alzheimer's & Dementia found that regular opioid use is associated with a 20% increased risk of all-cause dementia and over 70% increased risk of dementia among those taking strong opioids. Regular opioid use was also linked to reduced brain volume, lower fluid intelligence, and higher risk of vascular dementia.
A JAMA Psychiatry study recommends increasing contingency management incentives to improve opioid addiction recovery outcomes. The research team suggests using evidence-based incentive amounts, such as $128 per week for vouchers or $55 per week for prizes over 12 weeks, to effectively reduce stimulant and/or opioid use.
A new study found that Black emergency department patients are less likely to be treated with opioids, but when their preferences are not met, they are at a higher risk of misusing opioids three months later. Patients who were satisfied with their pain care had lower rates of opioid misuse.
A new study found that providing housing and supportive services without requiring drug treatment is a surprisingly cost-effective approach to helping unhoused people with opioid use disorder. The 'housing first' model output showed that people with stable housing are more likely to enter treatment for opioid use and have a higher like...
A new study found that almost all Medicaid managed care plans (MCPs) cover at least one form of naloxone, with 94% covering generic injectables or 4-mg nasal sprays. However, certain restrictions and quantity limits may prevent people from accessing this life-saving drug.